Pfizer seeks emergency use authorization for Covid-19 antiviral pill

The pill, called Paxlovid, was slightly less effective when given up to five days after patients presented symptoms, Pfizer said.

Availability of an oral medication that can treat Covid symptoms while keeping most patients out of the hospital could be a game changer for the course of the pandemic. Pills are easier to manufacture and distribute than therapies like monoclonal antibodies, which are administered by health care providers.

FDA is also considering an EUA application from Merck for an antiviral drug, molnupiravir, creating the prospect of two at-home coronavirus treatments being available, potentially in a matter of weeks.

What’s next: FDA’s independent advisers will meet on Nov. 30 to consider Merck’s application.

Source link

Be the first to comment

Leave a Reply

Your email address will not be published.


*